Abn-CBD
Tocris Bioscience, part of Bio-Techne | Catalog # 1297
Selective GPR55 agonist; neurobehaviorally inactive
Discontinued Product
1297 has been discontinued.
View all GPR55 Receptor Agonists products.
Key Product Details
Description
Selective GPR55 agonist; neurobehaviorally inactive
Alternative Names
Abnormal-cannabidiol
Product Description
Abn-CBD is a neurobehaviorally inactive cannabinoid that acts as a selective agonist for GPR55 (EC50 values are 2.5, >30 and >30 μM at GPR55, CB1 and CB2 receptors respectively). Increases phosphorylation of protein kinases in, and migration of, human umbilical vein endothelial cells.Product Specifications
Molecular Weight
314.47
Formula
C21H30O2
Storage
Desiccate at -20°C
Purity
≥97% (HPLC)
Chemical Name
4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol
CAS Number
22972-55-0
PubChem ID
89949
InChI Key
YWEZXUNAYVCODW-RBUKOAKNSA-N
SMILES
C=[C@](C)[C@@H]1CCC(C)=C[C@H]1[C@]2=C(O)C=C(O)C=C2CCCCC
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solubility | Soluble in methyl acetate (supplied pre-dissolved - 5mg/ml) |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Ryberg The orphan receptor GPR55 is a novel cannabinoid receptor. Br.J.Pharmacol. 2007 PMID: 17876302
- Jarai Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc.Natl.Acad.Sci.U.S.A. 1999 PMID: 10570211
- Mo Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Eur.J.Pharmacol. 2004 PMID: 15063151
- Ho and Hiley Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. Br.J.Pharmacol. 2003 PMID: 12711633
Product Specific Notices for Abn-CBD
For research use only
Loading...
Loading...